Table 3.
Five-year actuarial survival rates according to clinical and pathologic factors
| 5-y Survival rate (%) | |||
|---|---|---|---|
| Characteristic | No RT | RT | p |
| Clinical Stage | |||
| IIA | 100 | 100 | NA |
| IIB | 56 | 92 | 0.033 |
| IIIA | 50 | 66 | 0.154 |
| IIIB | 17 | 60 | 0.064 |
| IIIC | 0 | 33 | 0.56 |
| Clinical T stage | |||
| T1 | 100 | 100 | NA |
| T2 | 76 | 89 | 0.364 |
| T3 | 29 | 70 | 0.009 |
| T4 | 14 | 58 | 0.045 |
| Clinical N stage | |||
| N0 | 0 | 89 | 0.012 |
| N1 | 68 | 60 | 0.689 |
| N2 | 25 | 73 | 0.115 |
| N3 | 0 | 33 | 0.56 |
| Positive nodes (n) | |||
| 0 | 56 | 67 | 0.076 |
| 1–3 | 47 | 86 | 0.435 |
| >4 | 48 | 67 | 0.031 |
| LVSI | |||
| Present | 57 | 83 | 0.01 |
| Absent | 33 | 49 | 0.377 |
Abbreviations: NA = not applicable; other abbreviations as in Table 1.